Status:
COMPLETED
Caregiver Serological Monitoring Extended Secondarily to Patients With the SARS-CoV-2 Coronavirus
Lead Sponsor:
Hospices Civils de Lyon
Conditions:
COVID
Eligibility:
All Genders
Brief Summary
Hospital mortality attributed to SARS-CoV-2 in France increased daily by 28% in the week before confinement. The week following this decision, the daily increase was 30%. During the week of the second...
Eligibility Criteria
Inclusion
- Any adult having passed a serological, antigenical or any other type of test in France, and voluntary to participate in the cohort and/or vaccinated against COVID19
- Any child under 18 who has passed a serological, antigenical, or any other type of test in France, willing to participate and at least one of whose parents has accepted to participate in the cohort, and/or vaccinated against COVID19
Exclusion
- Persons deprived of their liberty
- Adults over whom legal protection applies: guardianship, curatorship
Key Trial Info
Start Date :
October 27 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 16 2022
Estimated Enrollment :
2777 Patients enrolled
Trial Details
Trial ID
NCT04441710
Start Date
October 27 2020
End Date
December 16 2022
Last Update
February 3 2023
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU de Grenoble - Hôpital Nord
La Tronche, France
2
Hôpital de la Croix Rousse
Lyon, France
3
CHU de Saint Etienne
Saint-Etienne, France
4
Hôpital Henry Gabrielle
Saint-Genis-Laval, France